UK-based company acquires Sophi

Phaco-emulsification is a commonly used cataract surgery method that requires the use of complex devices. Traditional methods that use merely gravitational force are prone to errors. Founded in 2014, This AG developed Sophi (Swiss Ophthalmology Innovation) the first wireless Phaco system equipped with an integrated air compressor to assist physicians, surgeons, OT staff and patients, providing mobility, simplicity, and safety within the operating theatre. With advanced features including triple pump fluidics, active IOP control, clean venturi and day cassette, cable-free power supply and wireless communication, Sophi presents a truly advanced surgical system.

The startup has entered a definitive acquisition agreement with Rayner, which throughout its 114-year history, has been at the forefront of innovation in ophthalmology and remains the only manufacturer of intraocular lenses in the UK. This acquisition marks a new chapter for Rayner as it branches out to include phaco technology as part of its extensive product portfolio.

Thomas Koeppel, founder and CEO of Sophi commented: “Sophi was created by viewing things from a completely new perspective; to redefine the requirements of a perfect phaco system by focusing on the point of view of the surgeon and their team. We saw the same philosophy in Rayner and are excited to combine in order to offer Sophi through an expanded commercial team and to accelerate our innovation projects.”

The acquisition will enhance Rayner’s breadth of high-quality products for cataract surgery, enabling the provision of a full offering also encompassing IOLs, OVDs, eye drops, pharmaceuticals, digital tools, and single-use recyclable instruments. As a newcomer to the Rayner product portfolio, Sophi comes highly regarded by medical professionals and is commended for its ease of use.

(Press release/RAN)